Objective To identify changes in the proteome associated with onset and progression of
hereditary transthyretin-mediated (hATTR) amyloidosis, also known as ATTRv amyloidosis, we …

Understanding mechanisms of hepatocellular damage may lead to new treatments for liver
disease, and genome-wide association studies (GWAS) of alanine aminotransferase (ALT) …

Background Hereditary transthyretin-mediated (hATTR) amyloidosis is a rare, progressively
debilitating, and fatal disease caused by deposition of aggregated TTR amyloid in multiple …

Objective: Evaluate the impact on circulating protein biomarkers in response to patisiran
treatment in patients with hATTR amyloidosis with polyneuropathy. Background: Hereditary …

Introduction Hereditary transthyretin-mediated (hATTR) amyloidosis is a progressive, life-threatening
disease due to deposition of transthyretin (TTR) amyloid in various organs and …

… Simina Ticau, Gautham Sridharan, Shira Tsour, William Cantley, Amy Chan, Jason Gilbert,
David Erbe, Kevin Fitzgerald, Akshay Vaishnaw, and Paul Nioi …

Introduction An estimated 3.1 million cases of myocarditis/cardiomyopathy were diagnosed
in 2017. Myocarditis, inflammation of the myocardium, is a leading cause of sudden death …

Introduction Hereditary transthyretin-mediated (hATTR) amyloidosis is a progressively
debilitating disease caused by mutations in the transthyretin (TTR) gene. The V122I variant, a …

Background and aims Individuals with a higher abdominal adipose tissue accumulation are
at higher risk of developing cardiometabolic diseases. For a given body mass index (BMI), …

Introduction L’amylose héréditaire à transthyrétine (hATTR) est une maladie rare engageant
le pronostic vital. Des biomarqueurs plasmatiques peuvent faciliter le diagnostic, évaluer le …